NEW YORK, March 31 - SAS today announced the launch of a new business unit dedicated to the life sciences market.
The new Life Sciences Organization is led by Kecia Serwin, who was formerly a sales director at the company. It will support healthcare providers, health insurers, and pharmaceutical, biotechnology and medical device companies.
The company has already identified several projects that the Life Sciences Organization will oversee, including support for biomedical customers in complying with the Food and Drug Administration's 21 CFR Part 11 regulations for the authentication of electronic documents. To meet this demand, SAS said that the Life Sciences Organization has launched the so-called Migration, Integration, and Validation (MIV) project to identify and address migration, integration, and validation issues related to achieving CFR Part 11 compliance.
For further information, see the press release.